Inventiva Sa (IVA) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · United States · ISIN US46124U1079
Inventiva Sa financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 9.20 m EUR | 4.48 m EUR |
| Gross profit | 9.20 m EUR | 1.51 m EUR |
| Operating income | -97.56 m EUR | -130.95 m EUR |
| EBIT | -171.72 m EUR | -130.95 m EUR |
| Net income | -184.21 m EUR | -340.16 m EUR |
| Diluted EPS – continuing operations | -3.54 EUR | -1.82 EUR |
Full history since 2013, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Inventiva Sa
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. Inventiva S.A. was incorporated in 2011 and is headquartered in Daix, France.
More stocks
- Westrock Coffee Co (WEST)
- Guangzhou Newlife New Material Co. Ltd. A (301323.SZ)
- BeiJing Certificate Authority Co Ltd (300579.SZ)
- Diversified Energy Co (DEC)
- China Motor Corp (2204.TW)
- Asiainfo Security Technologies Corp. A (688225.SS)
- Qt Group Oyj (QTCOM.HE)
- Cisen Pharmaceutical Co Ltd (603367.SS)
- KELLY SERVICES INC (KELYB)
- Karnov Group AB (publ) (KAR.ST)
- Controladora Vuela Compañía de Aviación S.A.B. de C.V (VOLARA.MX)
- Sichuan Xunyou Network Technology Co Ltd (300467.SZ)
Not investment advice. All data without warranty, price as of 05.11.2026. Details in the risk notice.